rethinkPeptides Search
Menu
Research citation

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

Science translational medicine, 9(402)

Citation

Alhadj Ali, Mohammad; Liu, Yuk-Fun; Arif, Sefina; Tatovic, Danijela; Shariff, Hina; Gibson, Vivienne B; Yusuf, Norkhairin; Baptista, Roman; Eichmann, Martin; Petrov, Nedyalko; Heck, Susanne; Yang, Jennie H M; Tree, Timothy I M; Pujol-Autonell, Irma; Yeo, Lorraine; Baumard, Lucas; Stenson, Rachel; Howell, Alex; Clark, Alison; Boult, Zoe; Powrie, Jake; Adams, Laura; Wong, Florence S; Luzio, Stephen; Dunseath, Gareth; Green, Kate; O'Keefe, Alison; Bayly, Graham; Thorogood, Natasha; Andrews, Robert; Leech, Nicola; Joseph, Frank; Nair, Sunil; Seal, Susan; Cheung, HoYee; Beam, Craig; Hills, Robert; Peakman, Mark; Dayan, Colin M. (2017). Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.. Science translational medicine, 9(402). https://doi.org/10.1126/scitranslmed.aaf7779